Expert Panel Develops NIH Treatment Guidelines for COVID-19

covid19treatmentguidelines.nih.gov
expert-panel-develops-nih-treatment-guidelines-for-covid-19

A panel of U.S. physicians, statisticians, and other experts has developed treatment guidelines for coronavirus disease 2019 (COVID-19). These guidelines, intended for healthcare providers, are based on published and preliminary data and the clinical expertise of the panelists, many of whom are frontline clinicians caring for patients during the rapidly evolving pandemic.

The guidelines are posted online and will be updated often as new data are published in peer-reviewed scientific literature and other authoritative information emerges.

The guidelines consider two broad categories of therapies currently in use by healthcare providers for COVID-19: antivirals, which may target the coronavirus directly, and host modifiers and immune-based therapies, which may influence the immune response to the virus or target the virus.

The panel’s conclusions about treating COVID-19 with various agents that fall into these two classes of therapies are distilled in summary recommendations. Subsequently, the document provides background information about each agent—such as clinical data about its use, ongoing clinical trials, and known interactions with other drugs—that forms the basis for the Recommendation. Tables briefly outline the same information.

The guidelines also include recommendations concerning the use of concomitant medications. These include statins: corticosteroids, non-steroidal anti-inflammatory drugs, and certain drugs used to control hypertension, known as ACE inhibitors and ARBs.

Read More